This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
J.M. Smucker's (SJM) Sale of Sahale Snacks to Refine Portfolio
by Zacks Equity Research
The J.M. Smucker (SJM) will offload its Sahale Snacks brand to Second Nature Brands to focus on areas with greater potential.
Celsius Holdings Inc. (CELH) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching Celsius Holdings Inc. (CELH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
United Natural (UNFI) Reports Q4 Loss, Lags Sales Estimate
by Zacks Equity Research
United Natural's (UNFI) fourth-quarter fiscal 2023 results reflect loss due to increased shrinkage and reduced inflationary benefits. Management expects these headwinds to persist in fiscal 2024.
Is Invesco S&P MidCap 400 Pure Growth ETF (RFG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RFG
Celsius Holdings Inc. (CELH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Celsius Holdings Inc. (CELH) closed at $167.53, marking a -1.64% move from the previous day.
Campbell Soup (CPB) Benefits From Savings Plan Amid High Costs
by Zacks Equity Research
Campbell Soup's (CPB) strategy of concentrating on supply-chain efficiencies and curtailing costs and reinvesting part of these savings in areas with high-growth potential bodes well.
Hormel Foods (HRL) Appears Dull on Supply-Chain, Cost Woes
by Zacks Equity Research
Hormel Foods (HRL) continues to operate in a volatile, complex and high-cost environment. Weakness in the International segment is a hurdle.
Lamb Weston (LW) Up More Than 20% in a Year: Will It Stay?
by Zacks Equity Research
Lamb Weston (LW) benefits from strategic pricing actions amid an inflationary environment. The company is boosting production capacity to fuel long-term growth.
Beat the Market Like Zacks: Elementis, Novo Nordisk, Amgen in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
B&G Foods (BGS) on Track With Pricing Efforts Amid Inflation
by Zacks Equity Research
B&G Foods' (BGS) focus on reshaping its portfolio is evident from its focus on making prudent buyouts and divestitures. Efficient pricing is shielding margins.
Vital Farms (VITL) Unveils Ambitious Long-Term Financial Goals
by Zacks Equity Research
Vital Farms (VITL) is on track to deliver on its long-term revenue and EBITDA goals, propelled by distribution point enhancement.
Is It Worth Investing in Celsius Holdings Inc. (CELH) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Celsius Holdings Inc. (CELH) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Celsius Holdings Inc. (CELH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Celsius Holdings Inc. (CELH) closed at $197.89 in the latest trading session, marking a -0.52% move from the prior day.
Tyson Foods (TSN) Gains on Improved Efficiency, Protein Demand
by Zacks Equity Research
Tyson Foods (TSN) is actively working on multiple fronts to improve its operations, reduce costs and meet market demand, while focusing on sustainability and long-term growth.
Kraft Heinz (KHC) Benefits From Pricing Actions Amid Costs
by Zacks Equity Research
Kraft Heinz (KHC) benefits from strategic pricing efforts amid an inflationary cost landscape. The company's AGILE@SCALE strategy holds promise.
Is Celsius (CELH) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how Celsius Holdings Inc. (CELH) and e.l.f. Beauty (ELF) have performed compared to their sector so far this year.
Hershey (HSY) Benefits From Pricing Amid High SG&A Costs
by Zacks Equity Research
Hershey's (HSY) effective pricing tactics and the resilience of its diverse brand portfolio have been providing support amid cost challenges.
Investors Heavily Search Celsius Holdings Inc. (CELH): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Celsius Holdings Inc. (CELH). This makes it worthwhile to examine what the stock has in store.
22nd Century (XXII) Expands VLN Cigarettes to 1,200 Drug Stores
by Zacks Equity Research
22nd Century Group's (XXII) VLN cigarettes represent a remarkable breakthrough as the first and only combustible cigarettes that the FDA has authorized as Modified Risk Tobacco Products.
Medifast (MED) Gains on OPTAVIA Lifestyle Solution Strength
by Zacks Equity Research
Medifast's (MED) OPTAVIA program is a robust and adaptable solution focused on health and wellness. This holistic approach positions it for sustained long-term growth.
22nd Century (XXII) Begins Strategic Review of Tobacco Assets
by Zacks Equity Research
22nd Century (XXII) is embarking on a strategic journey to unlock the full potential of its tobacco assets. This reflects the company's commitment to delivering long-term value to its shareholders.
Real Good Foods (RGF) Shines in US SPINS Retail Scanner Data
by Zacks Equity Research
The Real Good Food Company's (RGF) focus on strategic platforms like Breaded Chicken, Global Entrees, and Breakfast resonates with consumers who are increasingly seeking healthier food options.
SpartanNash (SPTN) Enhances Grocery Operations Using AI Tools
by Zacks Equity Research
SpartanNash's (SPTN) strategic partnership with Upshop to utilize Magic tool underscores its commitment to improve inventory management, customer experience and overall business efficiency.
Kimberly-Clark (KMB) is Poised on Growth Efforts, FORCE Program
by Zacks Equity Research
Kimberly-Clark (KMB) is navigating the evolving landscape of consumer goods with a strategic blueprint that encompasses innovation, market growth, cost control and digital transformation.
Beat the Market the Zacks Way: NVIDIA, Novo Nordisk, Matson in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.